Qinqiang Liu
Nanjing, 211166, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
miR-3651 Participates in the Growth Cycle of Hepatocellular Carcinoma Cells and Promotes the Malignant Metastasis via the PI3K/AKT/mTOR Signalling Pathway.
Journal: Journal of oncology
Published: July 06, 2022
De-methylation of miR-148a by arsenic trioxide enhances sensitivity to chemotherapy via inhibiting the NF-κB pathway and CSC like properties.
Journal: Experimental cell research
Published: July 29, 2019
Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1α.
Journal: Cell death discovery
Published: May 19, 2019
MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3ζ/STAT3/HIF-1α/VEGF signaling.
Journal: Oncotarget
Published: August 11, 2016
14-3-3η is a novel growth-promoting and angiogenic factor in hepatocellular carcinoma.
Journal: Journal of hepatology
Published: September 15, 2015
Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: October 12, 2014
Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
Journal: Toxicology letters
Published: August 06, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026